PAXLOVID HCP Lead

Since PAXLOVID’s emergency use authorization on 12/22/21, PAXLOVID has helped treat over 25M patients at high-risk from progression to severe COVID-19, which can lead to hospitalization and/or death. PAXLOVID is well-positioned to remain the gold standard in COVID-19 treatment, however the COVID-19 treatment landscape is a rapidly evolving space with significant complexity. Opportunity to increase treatment rates for eligible patients and bolster PAXLOVID’s leadership position in the marketplace continues.

New burden of disease studies and real-world evidence is anticipated throughout 2026 and beyond to help continue to support the treatment value proposition.

Since PAXLOVID’s emergency use authorization on 12/22/21, PAXLOVID has helped treat over 25M patients at high-risk from progression to severe COVID-19, which can lead to hospitalization and/or death. PAXLOVID is well-positioned to remain the gold standard in COVID-19 treatment, however the COVID-19 treatment landscape is a rapidly evolving space with significant complexity. Opportunity to increase treatment rates for eligible patients and bolster PAXLOVID’s leadership position in the marketplace continues.

New burden of disease studies and real-world evidence is anticipated throughout 2026 and beyond to help continue to support the treatment value proposition.

The Senior Director, HCP Team Lead, US Antiviral will report directly to the VP of US Antiviral and will be responsible for leading the development and execution of marketing strategies for U.S. HCPs in a complex and evolving market. The role will require the ability to work collaboratively with the U.S. Customer Engagement Platform (CEP) organization, the CMO, and other agency and cross-functional teams.

They will need to translate insights into action and identify business accelerators and innovative strategies to overcome market challenges and drive business. The ideal candidate will have high learning agility and demonstrated prior success in leading key marketing and strategic initiatives and demonstrate the ability to learn and adapt strategies and tactical execution quickly given how dynamic the marketplace is.

• Develop the overall HCP strategy and tactics to support appropriate utilization of PAXLOVID
• Support the development and implementation of annual tactical plans that drive the short- and long-term HCP strategy, based on key customer insights
• Member of the U.S. PAXLOVID leadership team; actively contributes to overall strategy for the brand, development of the team and accountability for the culture and environment
• Continuously own the measurement and impact of HCP marketing initiatives, generating key learnings, and driving continuous improvement in order to achieve brand objectives
• Ensures marketing materials are compelling and appropriate across all appropriate channels.
• Coordinate with IIS on the design and implementation of HCP market research to gain customer insights and monitor HCP performance trackers
• Partner with CEP, Commercial Effectiveness, and CMO teams to incorporate our Brand Strategic Customer Insights into broader field-based Targeting and Segmentation plans
• Partner with GCET to ensure new hire training adapts consistent with brand strategy and critical success factors
• Lead the U.S. POA meetings and other Sales Force meetings including planning, execution and follow-up engagement
• Manage U.S. PAXLOVID A&P budget and performance of the Agency of Record and other key partner agencies
• Collaborate and align with marketing team counterparts and cross-functional team members to ensure the plans work in synergy to deliver business objectives
• Conduct all responsibilities in accordance with Company policies, with a strong adherence to our…